amiodarone has been researched along with dalteparin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piazza, V; Rulli, F | 1 |
| Dragomanovits, S; Kalogeropoulos, AS; Kremastinos, DT; Papathanasiou, S; Rigopoulos, AG; Rizos, I; Sakadakis, EA; Tsiodras, S | 1 |
| Calzado-Villarreal, L; Gamo-Villegas, R; Gutierrez-Pascual, M; Lopez-Estebaranz, JL; Nuno-Gonzalez, A; Pinedo-Moraleda, F; Sanchez-Gilo, A; Sanz-Robles, H | 1 |
3 other study(ies) available for amiodarone and dalteparin
| Article | Year |
|---|---|
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.
Topics: Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Anticoagulants; Arteriosclerosis; Aspirin; Cardiology; Coronary Disease; Enoxaparin; Eptifibatide; Europe; Humans; Peptides; Platelet Aggregation Inhibitors; Societies, Medical; Thrombolytic Therapy | 1997 |
Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Enoxaparin; Female; Fibrinolytic Agents; Humans; Hypertension; Inflammation; Infusions, Intravenous; Interleukin-2; Interleukin-6; Male; Predictive Value of Tests; Remission Induction; Time; Time Factors | 2007 |
An unusual adverse effect of nadroparin injections: Calcinosis cutis.
Topics: Adult; Amiodarone; Anticoagulants; Atrial Fibrillation; Biopsy; Calcinosis; Calcium; Enoxaparin; Humans; Injections, Subcutaneous; Male; Nadroparin; Skin Diseases | 2011 |